Author Response: Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy

We would like to respond to the comments made by Pu Song and Xingshun Xu about the chosen administration of IV immunoglobulin (IVIG), which is based on a regimen for chronic inflammatory demyelinating polyneuropathy (CIPD). These authors also expressed doubts about our conclusion that IVIG was not effective in patients with painful with idiopathic small fiber neuropathy (I-SFN).

Read article at journal's website

Related Articles


Your email address will not be published.